Cargando…

Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more?

Detalles Bibliográficos
Autor principal:	LaCasse, Eric C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214455/ https://www.ncbi.nlm.nih.gov/pubmed/32393742 http://dx.doi.org/10.1038/s41419-020-2533-x

Ejemplares similares

IAP antagonist GDC-0917 is more potent than Debio1143 in promoting cell death, c-IAP1 degradation and tumor growth inhibition
por: Alicke, Bruno, et al.
Publicado: (2022)

The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice
por: Lei, Wei, et al.
Publicado: (2020)

Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression
por: Beug, Shawn T., et al.
Publicado: (2018)

Malaria prophylaxis: taking aim at constantly moving targets.
por: Bia, F. J.
Publicado: (1992)

Moving pathogen genomics out of the lab and into the clinic: what will it take?
por: Luheshi, Leila M., et al.
Publicado: (2015)

Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations
por: Issa, Amalia M., et al.
Publicado: (2018)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

Moving towards more patient-centred clinical trials in IBD
por: Noor, Nurulamin M., et al.
Publicado: (2021)

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
por: de Nonneville, Alexandre, et al.
Publicado: (2021)

If you can't take any more of this, please press two
por: Petsko, Gregory A
Publicado: (2002)

Role of the TWEAK-Fn14-cIAP1-NF-κB Signaling Axis in the Regulation of Myogenesis and Muscle Homeostasis
por: Enwere, Emeka K., et al.
Publicado: (2014)

Targeted ablation of the cellular inhibitor of apoptosis 1 (cIAP1) attenuates denervation-induced skeletal muscle atrophy
por: Lala-Tabbert, Neena, et al.
Publicado: (2019)

Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist
por: Liu, Xin, et al.
Publicado: (2022)

Nuclear Imaging Study of the Pharmacodynamic Effects of Debio 1143, an Antagonist of Multiple Inhibitor of Apoptosis Proteins (IAPs), in a Triple-Negative Breast Cancer Model
por: Bellaye, Pierre-Simon, et al.
Publicado: (2018)

AIMing 2 treat atherosclerosis
por: Soehnlein, Oliver, et al.
Publicado: (2022)

Inhibitor of apoptosis proteins, NAIP, cIAP1 and cIAP2 expression during macrophage differentiation and M1/M2 polarization
por: Morón-Calvente, Virginia, et al.
Publicado: (2018)

cIAP1 regulates the EGFR/Snai2 axis in triple-negative breast cancer cells
por: Majorini, Maria Teresa, et al.
Publicado: (2018)

Long COVID: aiming for a consensus
por: Munblit, Daniel, et al.
Publicado: (2022)

Bivalent IAP antagonists, but not monovalent IAP antagonists, inhibit TNF-mediated NF-κB signaling by degrading TRAF2-associated cIAP1 in cancer cells
por: Mitsuuchi, Y, et al.
Publicado: (2017)

Double take
por: Saxon, Emma
Publicado: (2015)

IAPs as E3 ligases of Rac1: Shaping the move
por: Oberoi-Khanuja, Tripat Kaur, et al.
Publicado: (2012)

IAPs on the move: role of inhibitors of apoptosis proteins in cell migration
por: Oberoi-Khanuja, T K, et al.
Publicado: (2013)

Moving forward with an imperfect vaccine
por: Pezzoli, Lorenzo, et al.
Publicado: (2021)

Computational biologists: moving to the driver's seat
por: Yanai, Itai, et al.
Publicado: (2017)

Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)

Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
por: McCabe, K E, et al.
Publicado: (2014)

The expanding role of IAP antagonists for the treatment of head and neck cancer
por: Kansal, Vikash, et al.
Publicado: (2023)

Shikonin promotes ubiquitination and degradation of cIAP1/2-mediated apoptosis and necrosis in triple negative breast cancer cells
por: Wang, Anqi, et al.
Publicado: (2021)

5th IAP Astrophysics Meeting
por: Audouze, Jean, et al.
Publicado: (1990)

The brain’s unique take on algorithms
por: Aimone, James B., et al.
Publicado: (2023)

Moving towards anti-racist praxis in medicine
por: Crear-Perry, Joia, et al.
Publicado: (2020)

Pandemic moves and countermoves: vaccines and viral variants
por: Sanders, Rogier W, et al.
Publicado: (2021)

2nd IAP Astrophysics Meeting
por: Audouze, Jean, et al.
Publicado: (1986)

Bivalent IAP antagonists inhibit TRAF2-bound cIAPs and limit TNF-mediated NF-κB signaling
por: Condon, Stephen M
Publicado: (2016)

Development of Peptidomimetics Targeting IAPs
por: Sharma, Sushil K., et al.
Publicado: (2006)

A Review of Natural Therapies Potentially Relevant in Triple Negative Breast Cancer Aimed at Targeting Cancer Cell Vulnerabilities
por: Webb, Myfanwy Jane, et al.
Publicado: (2020)

Drosophila IAP antagonists form multimeric complexes to promote cell death
por: Sandu, Cristinel, et al.
Publicado: (2010)

IAP antagonists sensitize murine osteosarcoma cells to killing by TNFα
por: Shekhar, Tanmay M., et al.
Publicado: (2016)

Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
por: Crawford, Nyree, et al.
Publicado: (2021)

A Mitochondrial Division Apparatus Takes Shape
por: van der Bliek, Alexander M.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_md7nce7bthg8so6c55kl636ioq